Source disclosure: March 02, 2026, 15:40 JST
Published by Pulse News Wire: March 02, 2026, 15:41 JST

Sumitomo Pharma Co.,Ltd. [4506.T]

TOKYO, Mar 02 (Pulse News Wire) – Sumitomo Pharma Co.,Ltd. (4506) has revised its FY2026/3 Full-Year consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: ) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 429,000 97,000 98,000 92,000 Revised Forecast (B) 449,000 107,000 108,000 102,000 Change (B-A) - 20,000 10,000 10,000 Change (%): Revenue +4.7% | OP +10.3% | OrdP +10.2% | NP +10.9% Prior Year Actual 398,832 43,153 28,804 23,634 KEY CHANGES: - Revenue forecast raised by +4.7% to 449,000 - Net profit forecast raised by +10.9% to 102,000 - Operating profit forecast raised by +10.3% to 107,000 REASON FOR REVISION: () 1 ¥145¥150 2004,490 1001,070 1001,080 1001,020 1

AI-translated content. 🟢 Confidence: High See terms • Original filing

💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.
🎁 Report 3+ errors with your email and get a free month of premium access